10/10/2026
Volatile anesthetics were proposed for ARDS due to potential anti-inflammatory, epithelial-protective, and respiratory effects. Promising preliminary data demonstrated reductions in inflammatory mediators and improvements in oxygenation. However, a recent multicenter randomized controlled trial found that sevoflurane sedation for patients with moderate-to-severe ARDS reduced ventilator-free days and increased mortality compared to propofol sedation.
Link in the first comment.